The New York Stock Exchange leads with seven of the 10 largest IPOs in 2025, paves way for digital currency public market debuts
Learn more
We set the standard with our unparalleled trading platform, enabling entrepreneurs, innovators, and investors to raise the capital they need to change the world. We want to share our vision for good governance, transparency, and trust with our listed community, furthering the responsible development of global business. You work too hard to list anywhere else.
Learn more
June 23, 2026 at 2:00 p.m. EST
It was a mixed session coming out of the long holiday weekend. Reports of progress in nuclear talks between Iran and the US helped stocks early on, continuing to pressure crude (down ~3%) however, yields saw no benefit from that rising ~5bp across the curve. The S&P 500 fell 0.4% with notable weakness in the mega-cap tech stocks (NYSE FANG+ -2.6%). Hyperscalers were the main target with that value continuing to accrete to semis and memory companies with the DRAM ETF climbing to new heights. Small and midcap indices ended with modest gains helped by strength in REITs, healthcare and financials. Energy stocks also ended higher despite the decline in oil with refiners picking up the slack.
A night’s sleep didn’t help matters. Asian equites were under significant pressure overnight, especially the high-flying chip/memory names which bled into European markets and US futures. The S&P 500 opened down ~1.5% nearly tagging its 50d ma (~7,340) but has since recouped some of those losses. Tech is once again bearing the brunt of the selling but the contours of that have changed with semis and particularly memory stocks getting hit hard (NYSE Semi -7%, DRAM ETF -12%). Much of the tech unwind seems to be positioning related. Outside of memory there wasn’t a particular headline that triggered the weakness but rather a culmination of narratives that have been evolving over the last couple of weeks, which we’ll touch on more below. Outside of the tech weakness the breadth is actually pretty solid with adv:dec in the S&P 500 ~1.5:1. Defensives, yield oriented sectors and YTD underperformers are leading to the upside.
| Description | Last | Change (%) |
|---|
| Description | Last | Change (%) |
|---|
| Description | Last | Change (%) |
|---|
| Description | Last | Change (%) |
|---|
| Description | Last | Change (%) |
|---|
Market data delayed minimum of 15 minutes
The NYSE looks forward to welcoming more leading companies from around the world in 2026, growing our one-of-a-kind community and setting the pace for innovation on a global scale. We’re endlessly inspired by the people behind these companies, check out their stories below and let’s make something happen together.
What does it take to go public? Ryan Hinkle draws on twenty years of investing at Insight Partners, one of the most prolific global software investors, and shares his advice for SaaS startups preparing to go public.
Entrepreneurs come to the NYSE to realize their ideas and change the world. We teamed up with 3M’s Post-it® Brand to encourage future leaders visiting our building to take a step toward making their goals and dreams happen. Watch as interns from Life Science Cares’ Project Onramp make their mark.

We asked some of the most curious minds in life sciences and healthcare to share thoughts on their careers, the future of health and more. Each participant drew questions and shared their insights, knowledge and some personal fun facts that left us inspired about the future of health and wellness.